The classification of stage III melanoma is complex and reflects the diverse prognostic outcomes of this heterogeneous group of patients. The latest iteration of the American Joint Committee on Cancer ...

New data shared in a poster presentation during the 19th European Association of Dermato-Oncology (EADO) Congress DecisionDx-Melanoma demonstrated improved risk-stratification of MSS with low-risk ...

Since 2009, the American Joint Committee on Cancer (AJCC; v7 and v8) Staging Manual for UM has specifically identified the GEP test as a prognostic factor that is recommended for collection as a ...